Global Nuclear Medicine/Radiopharmaceuticals Market Growth 2020-2025

  • receipt Report ID : 139582
  • calendar_today Published On: Nov, 2020
  • file_copy Pages: 134
  • list Pharmaceuticals and Healthcare
Buy @ $3660

According to this study, over the next five years the Nuclear Medicine/Radiopharmaceuticals market will register a 8.5%% CAGR in terms of revenue, the global market size will reach $ 7362.5 million by 2025, from $ 5317.4 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Nuclear Medicine/Radiopharmaceuticals business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine/Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Nuclear Medicine/Radiopharmaceuticals, covering the supply chain analysis, impact assessment to the Nuclear Medicine/Radiopharmaceuticals market size growth rate in several scenarios, and the measures to be undertaken by Nuclear Medicine/Radiopharmaceuticals companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

Diagnostic

Therapeutic

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

Oncology

Thyroid

Cardiology

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

China Isotope & Radiation

Dongcheng

Ciaeriar

Advanced Molecular-imaging Solution

Jaco

Shanghai Atom Kexing

...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Nuclear Medicine/Radiopharmaceuticals consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Nuclear Medicine/Radiopharmaceuticals market by identifying its various subsegments.

Focuses on the key global Nuclear Medicine/Radiopharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Nuclear Medicine/Radiopharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Nuclear Medicine/Radiopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption 2015-2025

2.1.2 Nuclear Medicine/Radiopharmaceuticals Consumption CAGR by Region

2.2 Nuclear Medicine/Radiopharmaceuticals Segment by Type

2.2.1 Diagnostic

2.2.2 Therapeutic

2.3 Nuclear Medicine/Radiopharmaceuticals Consumption by Type

2.3.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Type (2015-2020)

2.3.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Type (2015-2020)

2.3.3 Global Nuclear Medicine/Radiopharmaceuticals Sale Price by Type (2015-2020)

2.4 Nuclear Medicine/Radiopharmaceuticals Segment by Application

2.4.1 Oncology

2.4.2 Thyroid

2.4.3 Cardiology

2.5 Nuclear Medicine/Radiopharmaceuticals Consumption by Application

2.5.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Type (2015-2020)

2.5.2 Global Nuclear Medicine/Radiopharmaceuticals Value and Market Share by Type (2015-2020)

2.5.3 Global Nuclear Medicine/Radiopharmaceuticals Sale Price by Type (2015-2020)

3 Global Nuclear Medicine/Radiopharmaceuticals by Company

3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company

3.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Company (2018-2020)

3.1.2 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2018-2020)

3.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Company

3.2.1 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Company (2018-2020)

3.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Company (2018-2020)

3.3 Global Nuclear Medicine/Radiopharmaceuticals Sale Price by Company

3.4 Global Nuclear Medicine/Radiopharmaceuticals Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Nuclear Medicine/Radiopharmaceuticals Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Nuclear Medicine/Radiopharmaceuticals Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Nuclear Medicine/Radiopharmaceuticals by Regions

4.1 Nuclear Medicine/Radiopharmaceuticals by Regions

4.2 Americas Nuclear Medicine/Radiopharmaceuticals Consumption Growth

4.3 APAC Nuclear Medicine/Radiopharmaceuticals Consumption Growth

4.4 Europe Nuclear Medicine/Radiopharmaceuticals Consumption Growth

4.5 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption Growth

5 Americas

5.1 Americas Nuclear Medicine/Radiopharmaceuticals Consumption by Countries

5.1.1 Americas Nuclear Medicine/Radiopharmaceuticals Consumption by Countries (2015-2020)

5.1.2 Americas Nuclear Medicine/Radiopharmaceuticals Value by Countries (2015-2020)

5.2 Americas Nuclear Medicine/Radiopharmaceuticals Consumption by Type

5.3 Americas Nuclear Medicine/Radiopharmaceuticals Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Nuclear Medicine/Radiopharmaceuticals Consumption by Regions

6.1.1 APAC Nuclear Medicine/Radiopharmaceuticals Consumption by Regions (2015-2020)

6.1.2 APAC Nuclear Medicine/Radiopharmaceuticals Value by Regions (2015-2020)

6.2 APAC Nuclear Medicine/Radiopharmaceuticals Consumption by Type

6.3 APAC Nuclear Medicine/Radiopharmaceuticals Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Nuclear Medicine/Radiopharmaceuticals by Countries

7.1.1 Europe Nuclear Medicine/Radiopharmaceuticals Consumption by Countries (2015-2020)

7.1.2 Europe Nuclear Medicine/Radiopharmaceuticals Value by Countries (2015-2020)

7.2 Europe Nuclear Medicine/Radiopharmaceuticals Consumption by Type

7.3 Europe Nuclear Medicine/Radiopharmaceuticals Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals by Countries

8.1.1 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Value by Countries (2015-2020)

8.2 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption by Type

8.3 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Nuclear Medicine/Radiopharmaceuticals Distributors

10.3 Nuclear Medicine/Radiopharmaceuticals Customer

11 Global Nuclear Medicine/Radiopharmaceuticals Market Forecast

11.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption Forecast (2021-2025)

11.2 Global Nuclear Medicine/Radiopharmaceuticals Forecast by Regions

11.2.1 Global Nuclear Medicine/Radiopharmaceuticals Forecast by Regions (2021-2025)

11.2.2 Global Nuclear Medicine/Radiopharmaceuticals Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Nuclear Medicine/Radiopharmaceuticals Forecast by Type

11.8 Global Nuclear Medicine/Radiopharmaceuticals Forecast by Application

12 Key Players Analysis

12.1 China Isotope & Radiation

12.1.1 Company Information

12.1.2 Nuclear Medicine/Radiopharmaceuticals Product Offered

12.1.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 China Isotope & Radiation Latest Developments

12.2 Dongcheng

12.2.1 Company Information

12.2.2 Nuclear Medicine/Radiopharmaceuticals Product Offered

12.2.3 Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 Dongcheng Latest Developments

12.3 Ciaeriar

12.3.1 Company Information

12.3.2 Nuclear Medicine/Radiopharmaceuticals Product Offered

12.3.3 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 Ciaeriar Latest Developments

12.4 Advanced Molecular-imaging Solution

12.4.1 Company Information

12.4.2 Nuclear Medicine/Radiopharmaceuticals Product Offered

12.4.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Advanced Molecular-imaging Solution Latest Developments

12.5 Jaco

12.5.1 Company Information

12.5.2 Nuclear Medicine/Radiopharmaceuticals Product Offered

12.5.3 Jaco Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 Jaco Latest Developments

12.6 Shanghai Atom Kexing

12.6.1 Company Information

12.6.2 Nuclear Medicine/Radiopharmaceuticals Product Offered

12.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 Shanghai Atom Kexing Latest Developments

...

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Nuclear Medicine/Radiopharmaceuticals Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of Diagnostic

Table 5. Major Players of Therapeutic

Table 6. Global Consumption Sales by Type (2015-2020)

Table 7. Global Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Type (2015-2020)

Table 8. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2015-2020) ($ million)

Table 9. Global Nuclear Medicine/Radiopharmaceuticals Value Market Share by Type (2015-2020) ($ Millions)

Table 10. Global Nuclear Medicine/Radiopharmaceuticals Sale Price by Type (2015-2020)

Table 11. Global Consumption Sales by Application (2015-2020)

Table 12. Global Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Application (2015-2020)

Table 13. Global Nuclear Medicine/Radiopharmaceuticals Value by Application (2015-2020)

Table 14. Global Nuclear Medicine/Radiopharmaceuticals Value Market Share by Application (2015-2020)

Table 15. Global Nuclear Medicine/Radiopharmaceuticals Sale Price by Application (2015-2020)

Table 16. Global Nuclear Medicine/Radiopharmaceuticals Sales by Company (2017-2019) (K Units)

Table 17. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2017-2019)

Table 18. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Company (2017-2019) ($ Millions)

Table 19. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Company (2017-2019)

Table 20. Global Nuclear Medicine/Radiopharmaceuticals Sale Price by Company (2017-2019)

Table 21. Global Nuclear Medicine/Radiopharmaceuticals Manufacturing Base Distribution and Sales Area by Manufacturers

Table 22. Players Nuclear Medicine/Radiopharmaceuticals Products Offered

Table 23. Nuclear Medicine/Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 24. Global Nuclear Medicine/Radiopharmaceuticals Consumption by Regions 2015-2020 (K Units)

Table 25. Global Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Regions 2015-2020

Table 26. Global Nuclear Medicine/Radiopharmaceuticals Value by Regions 2015-2020 ($ Millions)

Table 27. Global Nuclear Medicine/Radiopharmaceuticals Value Market Share by Regions 2015-2020

Table 28. Americas Nuclear Medicine/Radiopharmaceuticals Consumption by Countries (2015-2020) (K Units)

Table 29. Americas Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Countries (2015-2020)

Table 30. Americas Nuclear Medicine/Radiopharmaceuticals Value by Countries (2015-2020) ($ Millions)

Table 31. Americas Nuclear Medicine/Radiopharmaceuticals Value Market Share by Countries (2015-2020)

Table 32. Americas Nuclear Medicine/Radiopharmaceuticals Consumption by Type (2015-2020) (K Units)

Table 33. Americas Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Type (2015-2020)

Table 34. Americas Nuclear Medicine/Radiopharmaceuticals Consumption by Application (2015-2020) (K Units)

Table 35. Americas Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Application (2015-2020)

Table 36. APAC Nuclear Medicine/Radiopharmaceuticals Consumption by Countries (2015-2020) (K Units)

Table 37. APAC Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Countries (2015-2020)

Table 38. APAC Nuclear Medicine/Radiopharmaceuticals Value by Regions (2015-2020) ($ Millions)

Table 39. APAC Nuclear Medicine/Radiopharmaceuticals Value Market Share by Regions (2015-2020)

Table 40. APAC Nuclear Medicine/Radiopharmaceuticals Consumption by Type (2015-2020) (K Units)

Table 41. APAC Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Type (2015-2020)

Table 42. APAC Nuclear Medicine/Radiopharmaceuticals Consumption by Application (2015-2020) (K Units)

Table 43. APAC Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Application (2015-2020)

Table 44. Europe Nuclear Medicine/Radiopharmaceuticals Consumption by Countries (2015-2020) (K Units)

Table 45. Europe Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Countries (2015-2020)

Table 46. Europe Nuclear Medicine/Radiopharmaceuticals Value by Countries (2015-2020) ($ Millions)

Table 47. Europe Nuclear Medicine/Radiopharmaceuticals Value Market Share by Countries (2015-2020)

Table 48. Europe Nuclear Medicine/Radiopharmaceuticals Consumption by Type (2015-2020) (K Units)

Table 49. Europe Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Type (2015-2020)

Table 50. Europe Nuclear Medicine/Radiopharmaceuticals Consumption by Application (2015-2020) (K Units)

Table 51. Europe Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Application (2015-2020)

Table 52. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption by Countries (2015-2020) (K Units)

Table 53. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Countries (2015-2020)

Table 54. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Value by Countries (2015-2020) ($ Millions)

Table 55. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Value Market Share by Countries (2015-2020)

Table 56. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption by Type (2015-2020) (K Units)

Table 57. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Type (2015-2020)

Table 58. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption by Application (2015-2020) (K Units)

Table 59. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Application (2015-2020)

Table 60. Nuclear Medicine/Radiopharmaceuticals Distributors List

Table 61. Nuclear Medicine/Radiopharmaceuticals Customer List

Table 62. Global Nuclear Medicine/Radiopharmaceuticals Consumption Forecast by Countries (2021-2025) (K Units)

Table 63. Global Nuclear Medicine/Radiopharmaceuticals Consumption Market Forecast by Regions

Table 64. Global Nuclear Medicine/Radiopharmaceuticals Value Forecast by Countries (2021-2025) ($ Millions)

Table 65. Global Nuclear Medicine/Radiopharmaceuticals Value Market Share Forecast by Regions

Table 66. Global Nuclear Medicine/Radiopharmaceuticals Consumption Forecast by Type (2021-2025) (K Units)

Table 67. Global Nuclear Medicine/Radiopharmaceuticals Consumption Market Share Forecast by Type (2021-2025)

Table 68. Global Nuclear Medicine/Radiopharmaceuticals Value Forecast by Type (2021-2025) ($ Millions)

Table 69. Global Nuclear Medicine/Radiopharmaceuticals Value Market Share Forecast by Type (2021-2025)

Table 70. Global Nuclear Medicine/Radiopharmaceuticals Consumption Forecast by Application (2021-2025) (K Units)

Table 71. Global Nuclear Medicine/Radiopharmaceuticals Consumption Market Share Forecast by Application (2021-2025)

Table 72. Global Nuclear Medicine/Radiopharmaceuticals Value Forecast by Application (2021-2025) ($ Millions)

Table 73. Global Nuclear Medicine/Radiopharmaceuticals Value Market Share Forecast by Application (2021-2025)

Table 74. China Isotope & Radiation Product Offered

Table 75. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 76. China Isotope & Radiation Main Business

Table 77. China Isotope & Radiation Latest Developments

Table 78. China Isotope & Radiation Basic Information, Company Total Revenue (in $ million), Nuclear Medicine/Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 79. Dongcheng Product Offered

Table 80. Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 81. Dongcheng Main Business

Table 82. Dongcheng Latest Developments

Table 83. Dongcheng Basic Information, Company Total Revenue (in $ million), Nuclear Medicine/Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 84. Ciaeriar Product Offered

Table 85. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 86. Ciaeriar Main Business

Table 87. Ciaeriar Latest Developments

Table 88. Ciaeriar Basic Information, Company Total Revenue (in $ million), Nuclear Medicine/Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 89. Advanced Molecular-imaging Solution Product Offered

Table 90. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 91. Advanced Molecular-imaging Solution Main Business

Table 92. Advanced Molecular-imaging Solution Latest Developments

Table 93. Advanced Molecular-imaging Solution Basic Information, Company Total Revenue (in $ million), Nuclear Medicine/Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 94. Jaco Product Offered

Table 95. Jaco Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 96. Jaco Main Business

Table 97. Jaco Latest Developments

Table 98. Jaco Basic Information, Company Total Revenue (in $ million), Nuclear Medicine/Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 99. Shanghai Atom Kexing Product Offered

Table 100. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 101. Shanghai Atom Kexing Main Business

Table 102. Shanghai Atom Kexing Latest Developments

Table 103. Shanghai Atom Kexing Basic Information, Company Total Revenue (in $ million), Nuclear Medicine/Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Nuclear Medicine/Radiopharmaceuticals

Figure 2. Nuclear Medicine/Radiopharmaceuticals Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global Nuclear Medicine/Radiopharmaceuticals Consumption Growth Rate 2015-2025 (K Units)

Figure 5. Global Nuclear Medicine/Radiopharmaceuticals Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of Diagnostic

Figure 7. Product Picture of Therapeutic

Figure 8. Global Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Type (2015-2020)

Figure 9. Global Nuclear Medicine/Radiopharmaceuticals Value Market Share by Type (2015-2020)

Figure 10. Nuclear Medicine/Radiopharmaceuticals Consumed in Oncology

Figure 11. Global Nuclear Medicine/Radiopharmaceuticals Market: Oncology (2015-2020) (K Units)

Figure 12. Global Nuclear Medicine/Radiopharmaceuticals Market: Oncology (2015-2020) ($ Millions)

Figure 13. Nuclear Medicine/Radiopharmaceuticals Consumed in Thyroid

Figure 14. Global Nuclear Medicine/Radiopharmaceuticals Market: Thyroid (2015-2020) (K Units)

Figure 15. Global Nuclear Medicine/Radiopharmaceuticals Market: Thyroid (2015-2020) ($ Millions)

Figure 16. Nuclear Medicine/Radiopharmaceuticals Consumed in Cardiology

Figure 17. Global Nuclear Medicine/Radiopharmaceuticals Market: Cardiology (2015-2020) (K Units)

Figure 18. Global Nuclear Medicine/Radiopharmaceuticals Market: Cardiology (2015-2020) ($ Millions)

Figure 19. Global Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Application (2015-2020)

Figure 20. Global Nuclear Medicine/Radiopharmaceuticals Value Market Share by Application (2015-2020)

Figure 21. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company in 2017

Figure 22. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company in 2019

Figure 23. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Company in 2017

Figure 24. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Company in 2019

Figure 25. Global Nuclear Medicine/Radiopharmaceuticals Sale Price by Company in 2019

Figure 26. Global Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Regions 2015-2020

Figure 27. Global Nuclear Medicine/Radiopharmaceuticals Value Market Share by Regions 2015-2020

Figure 28. Americas Nuclear Medicine/Radiopharmaceuticals Consumption 2015-2020 (K Units)

Figure 29. Americas Nuclear Medicine/Radiopharmaceuticals Value 2015-2020 ($ Millions)

Figure 30. APAC Nuclear Medicine/Radiopharmaceuticals Consumption 2015-2020 (K Units)

Figure 31. APAC Nuclear Medicine/Radiopharmaceuticals Value 2015-2020 ($ Millions)

Figure 32. Europe Nuclear Medicine/Radiopharmaceuticals Consumption 2015-2020 (K Units)

Figure 33. Europe Nuclear Medicine/Radiopharmaceuticals Value 2015-2020 ($ Millions)

Figure 34. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption 2015-2020 (K Units)

Figure 35. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Value 2015-2020 ($ Millions)

Figure 36. Americas Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Countries in 2019

Figure 37. Americas Nuclear Medicine/Radiopharmaceuticals Value Market Share by Countries in 2019

Figure 38. Americas Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Type in 2019

Figure 39. Americas Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Application in 2019

Figure 40. United States Nuclear Medicine/Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)

Figure 41. United States Nuclear Medicine/Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)

Figure 42. Canada Nuclear Medicine/Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)

Figure 43. Canada Nuclear Medicine/Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)

Figure 44. Mexico Nuclear Medicine/Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)

Figure 45. Mexico Nuclear Medicine/Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)

Figure 46. APAC Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Countries in 2019

Figure 47. APAC Nuclear Medicine/Radiopharmaceuticals Value Market Share by Regions in 2019

Figure 48. APAC Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Type in 2019

Figure 49. APAC Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Application in 2019

Figure 50. China Nuclear Medicine/Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)

Figure 51. China Nuclear Medicine/Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)

Figure 52. Japan Nuclear Medicine/Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)

Figure 53. Japan Nuclear Medicine/Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)

Figure 54. Korea Nuclear Medicine/Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)

Figure 55. Korea Nuclear Medicine/Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)

Figure 56. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)

Figure 57. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)

Figure 58. India Nuclear Medicine/Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)

Figure 59. India Nuclear Medicine/Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)

Figure 60. Australia Nuclear Medicine/Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)

Figure 61. Australia Nuclear Medicine/Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)

Figure 62. Europe Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Countries in 2019

Figure 63. Europe Nuclear Medicine/Radiopharmaceuticals Value Market Share by Countries in 2019

Figure 64. Europe Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Type in 2019

Figure 65. Europe Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Application in 2019

Figure 66. Germany Nuclear Medicine/Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)

Figure 67. Germany Nuclear Medicine/Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)

Figure 68. France Nuclear Medicine/Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)

Figure 69. France Nuclear Medicine/Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)

Figure 70. UK Nuclear Medicine/Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)

Figure 71. UK Nuclear Medicine/Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)

Figure 72. Italy Nuclear Medicine/Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)

Figure 73. Italy Nuclear Medicine/Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)

Figure 74. Russia Nuclear Medicine/Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)

Figure 75. Russia Nuclear Medicine/Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)

Figure 76. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Countries in 2019

Figure 77. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Value Market Share by Countries in 2019

Figure 78. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Type in 2019

Figure 79. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Application in 2019

Figure 80. Egypt Nuclear Medicine/Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)

Figure 81. Egypt Nuclear Medicine/Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)

Figure 82. South Africa Nuclear Medicine/Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)

Figure 83. South Africa Nuclear Medicine/Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)

Figure 84. Israel Nuclear Medicine/Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)

Figure 85. Israel Nuclear Medicine/Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)

Figure 86. Turkey Nuclear Medicine/Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)

Figure 87. Turkey Nuclear Medicine/Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)

Figure 88. GCC Countries Nuclear Medicine/Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)

Figure 89. GCC Countries Nuclear Medicine/Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)

Figure 90. Global Nuclear Medicine/Radiopharmaceuticals Consumption Growth Rate Forecast (2021-2025) (K Units)

Figure 91. Global Nuclear Medicine/Radiopharmaceuticals Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 92. Americas Nuclear Medicine/Radiopharmaceuticals Consumption 2021-2025 (K Units)

Figure 93. Americas Nuclear Medicine/Radiopharmaceuticals Value 2021-2025 ($ Millions)

Figure 94. APAC Nuclear Medicine/Radiopharmaceuticals Consumption 2021-2025 (K Units)

Figure 95. APAC Nuclear Medicine/Radiopharmaceuticals Value 2021-2025 ($ Millions)

Figure 96. Europe Nuclear Medicine/Radiopharmaceuticals Consumption 2021-2025 (K Units)

Figure 97. Europe Nuclear Medicine/Radiopharmaceuticals Value 2021-2025 ($ Millions)

Figure 98. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption 2021-2025 (K Units)

Figure 99. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Value 2021-2025 ($ Millions)

Figure 100. United States Nuclear Medicine/Radiopharmaceuticals Consumption 2021-2025 (K Units)

Figure 101. United States Nuclear Medicine/Radiopharmaceuticals Value 2021-2025 ($ Millions)

Figure 102. Canada Nuclear Medicine/Radiopharmaceuticals Consumption 2021-2025 (K Units)

Figure 103. Canada Nuclear Medicine/Radiopharmaceuticals Value 2021-2025 ($ Millions)

Figure 104. Mexico Nuclear Medicine/Radiopharmaceuticals Consumption 2021-2025 (K Units)

Figure 105. Mexico Nuclear Medicine/Radiopharmaceuticals Value 2021-2025 ($ Millions)

Figure 106. Brazil Nuclear Medicine/Radiopharmaceuticals Consumption 2021-2025 (K Units)

Figure 107. Brazil Nuclear Medicine/Radiopharmaceuticals Value 2021-2025 ($ Millions)

Figure 108. China Nuclear Medicine/Radiopharmaceuticals Consumption 2021-2025 (K Units)

Figure 109. China Nuclear Medicine/Radiopharmaceuticals Value 2021-2025 ($ Millions)

Figure 110. Japan Nuclear Medicine/Radiopharmaceuticals Consumption 2021-2025 (K Units)

Figure 111. Japan Nuclear Medicine/Radiopharmaceuticals Value 2021-2025 ($ Millions)

Figure 112. Korea Nuclear Medicine/Radiopharmaceuticals Consumption 2021-2025 (K Units)

Figure 113. Korea Nuclear Medicine/Radiopharmaceuticals Value 2021-2025 ($ Millions)

Figure 114. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Consumption 2021-2025 (K Units)

Figure 115. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Value 2021-2025 ($ Millions)

Figure 116. India Nuclear Medicine/Radiopharmaceuticals Consumption 2021-2025 (K Units)

Figure 117. India Nuclear Medicine/Radiopharmaceuticals Value 2021-2025 ($ Millions)

Figure 118. Australia Nuclear Medicine/Radiopharmaceuticals Consumption 2021-2025 (K Units)

Figure 119. Australia Nuclear Medicine/Radiopharmaceuticals Value 2021-2025 ($ Millions)

Figure 120. Germany Nuclear Medicine/Radiopharmaceuticals Consumption 2021-2025 (K Units)

Figure 121. Germany Nuclear Medicine/Radiopharmaceuticals Value 2021-2025 ($ Millions)

Figure 122. France Nuclear Medicine/Radiopharmaceuticals Consumption 2021-2025 (K Units)

Figure 123. France Nuclear Medicine/Radiopharmaceuticals Value 2021-2025 ($ Millions)

Figure 124. UK Nuclear Medicine/Radiopharmaceuticals Consumption 2021-2025 (K Units)

Figure 125. UK Nuclear Medicine/Radiopharmaceuticals Value 2021-2025 ($ Millions)

Figure 126. Italy Nuclear Medicine/Radiopharmaceuticals Consumption 2021-2025 (K Units)

Figure 127. Italy Nuclear Medicine/Radiopharmaceuticals Value 2021-2025 ($ Millions)

Figure 128. Russia Nuclear Medicine/Radiopharmaceuticals Consumption 2021-2025 (K Units)

Figure 129. Russia Nuclear Medicine/Radiopharmaceuticals Value 2021-2025 ($ Millions)

Figure 130. Spain Nuclear Medicine/Radiopharmaceuticals Consumption 2021-2025 (K Units)

Figure 131. Spain Nuclear Medicine/Radiopharmaceuticals Value 2021-2025 ($ Millions)

Figure 132. Egypt Nuclear Medicine/Radiopharmaceuticals Consumption 2021-2025 (K Units)

Figure 133. Egypt Nuclear Medicine/Radiopharmaceuticals Value 2021-2025 ($ Millions)

Figure 134. South Africa Nuclear Medicine/Radiopharmaceuticals Consumption 2021-2025 (K Units)

Figure 135. South Africa Nuclear Medicine/Radiopharmaceuticals Value 2021-2025 ($ Millions)

Figure 136. Israel Nuclear Medicine/Radiopharmaceuticals Consumption 2021-2025 (K Units)

Figure 137. Israel Nuclear Medicine/Radiopharmaceuticals Value 2021-2025 ($ Millions)

Figure 138. Turkey Nuclear Medicine/Radiopharmaceuticals Consumption 2021-2025 (K Units)

Figure 139. Turkey Nuclear Medicine/Radiopharmaceuticals Value 2021-2025 ($ Millions)

Figure 140. GCC Countries Nuclear Medicine/Radiopharmaceuticals Consumption 2021-2025 (K Units)

Figure 141. GCC Countries Nuclear Medicine/Radiopharmaceuticals Value 2021-2025 ($ Millions)

Figure 142. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Market Share (2018-2020)

Figure 143. Dongcheng Nuclear Medicine/Radiopharmaceuticals Market Share (2018-2020)

Figure 144. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Market Share (2018-2020)

Figure 145. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Market Share (2018-2020)

Figure 146. Jaco Nuclear Medicine/Radiopharmaceuticals Market Share (2018-2020)

Figure 147. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Market Share (2018-2020)